Experience

STVP - the Stanford Engineering Entrepreneurship Center

• United States
• Higher Education
• 1 - 100 Employee

• Mayfield Fellow 2023

  • Nov 2022 - Present

  One of twelve people selected to participate in an entrepreneurial fellowship to develop the theoretical understanding, practical knowledge and leadership skills needed to establish, scale, and lead principled and responsible tech ventures. Notable alumni: Kevin Systrom (Instagram), Justin Rosenstein (Asana), Josh Reeves (Gusto) One of twelve people selected to participate in an entrepreneurial fellowship to develop the theoretical understanding, practical knowledge and leadership skills needed to establish, scale, and lead principled and responsible tech ventures. Notable alumni: Kevin Systrom (Instagram), Justin Rosenstein (Asana), Josh Reeves (Gusto)



Stealth Startup

• United States
• Technology, Information and Internet
• 700 & Above Employee

• Business Development Fellow

  • Jun 2023 - Sep 2023

  Mayfield Fellow at an Illumina-backed Stealth Startup Mayfield Fellow at an Illumina-backed Stealth Startup



Stanford Institute for Stem Cell Biology and Regenerative Medicine

• Hospitals and Health Care
• 1 - 100 Employee

• Researcher

  • Mar 2022 - Jun 2023

  Co-lead on a novel concept, using 3D bioprinting technology to develop a surgical procedure involving cartilage regeneration to address craniofacial defects from birth deformities or trauma. Our team, equipped with the expertise of professors, surgeons, and engineers, hope to produce clinically relevant results as a harbinger of less invasive approaches to craniofacial modification. Co-lead on a novel concept, using 3D bioprinting technology to develop a surgical procedure involving cartilage regeneration to address craniofacial defects from birth deformities or trauma. Our team, equipped with the expertise of professors, surgeons, and engineers, hope to produce clinically relevant results as a harbinger of less invasive approaches to craniofacial modification.



iGEM Competition

• United States
• Biotechnology Research
• 100 - 200 Employee

• iGEM - International Genetically Engineered Machine Project Researcher

  • Mar 2021 - Oct 2022

  Created a method of inactivating (blocking) the furanocoumarins from interacting with the CYP enzymes. Our team discovered previous research suggesting that CYP 6YP1B enzymes found in black swallowtail butterflies can degrade furanocoumarins (Dongfack, 2012). We utilised this gene to digest the FCs to the point where they are unable to interact with the cytochromes responsible for drug metabolism. We plan to engineer gut microbes, particularly Saccharomyces cerevisiae (Brewer’s Yeast) as they… Show more Created a method of inactivating (blocking) the furanocoumarins from interacting with the CYP enzymes. Our team discovered previous research suggesting that CYP 6YP1B enzymes found in black swallowtail butterflies can degrade furanocoumarins (Dongfack, 2012). We utilised this gene to digest the FCs to the point where they are unable to interact with the cytochromes responsible for drug metabolism. We plan to engineer gut microbes, particularly Saccharomyces cerevisiae (Brewer’s Yeast) as they are eukaryotic organisms, which have more organelles in comparison to prokaryotes such as E. Coli, which would allow for better expression of effective protein structures. • Project management role • Conducted user interviews for patients and other academic professionals to streamline our project. • Built wetlab experience with cell culturing, spectrophotometry, plasmid design on benchling Show less Created a method of inactivating (blocking) the furanocoumarins from interacting with the CYP enzymes. Our team discovered previous research suggesting that CYP 6YP1B enzymes found in black swallowtail butterflies can degrade furanocoumarins (Dongfack, 2012). We utilised this gene to digest the FCs to the point where they are unable to interact with the cytochromes responsible for drug metabolism. We plan to engineer gut microbes, particularly Saccharomyces cerevisiae (Brewer’s Yeast) as they… Show more Created a method of inactivating (blocking) the furanocoumarins from interacting with the CYP enzymes. Our team discovered previous research suggesting that CYP 6YP1B enzymes found in black swallowtail butterflies can degrade furanocoumarins (Dongfack, 2012). We utilised this gene to digest the FCs to the point where they are unable to interact with the cytochromes responsible for drug metabolism. We plan to engineer gut microbes, particularly Saccharomyces cerevisiae (Brewer’s Yeast) as they are eukaryotic organisms, which have more organelles in comparison to prokaryotes such as E. Coli, which would allow for better expression of effective protein structures. • Project management role • Conducted user interviews for patients and other academic professionals to streamline our project. • Built wetlab experience with cell culturing, spectrophotometry, plasmid design on benchling Show less



Hollister Co.

• United States
• Retail
• 700 & Above Employee

• Brand Representative

  • Jun 2019 - Aug 2019



New Zealand Olympic Committee

• New Zealand
• Spectator Sports
• 1 - 100 Employee

• Long-Listed Athlete

  • Mar 2019 - Jun 2019

  Long-listed Athlete for the NZOC. Reserve Spot Holder for the 2019 Pacific Games (Continental Qualifying Tournament) in Archery. Long-listed Athlete for the NZOC. Reserve Spot Holder for the 2019 Pacific Games (Continental Qualifying Tournament) in Archery.